A new test could save arthritis patients time, money, and pain. But will it be used?

Erinn Maury knew Remicade wasn’t the right drug for Patti Schulte, a rheumatoid arthritis patient the physician saw at her Millersville, Maryland, practice. Schulte’s swollen, painful joints hadn’t responded to Enbrel or Humira, two drugs in the same class.

Merrimack to dissolve after recording $225M milestone; Cogent’s $225M placement

Plus, news about Larimar Therapeutics, Metagenomi, NextPoint Therapeutics, MeiraGTx, Codexis, Invitae, Immunome and BioXcel Therapeutics: Ipsen to pay $225M to Merrimack Pharmaceuticals: The milestone payout

February 15, 2024

Gavi announces $1.8B for vaccine access, pandemic preparedness efforts in Africa

The global health partnership Gavi is looking to ramp up vaccine access in Africa through a slate of programs that puts up $1.8 billion to

December 9, 2023

Researchers sound a clarion call for greater investment in bereavement care

The public health toll from bereavement is well-documented in the medical literature, with bereaved persons at greater risk for many adverse outcomes, including mental health

March 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.